Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NK Cells and Mogamulizumab in CTCL and ATLL
NCT04848064Phase 1Recruiting
- Start
- May 2022
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
Phase 1, open-label trial in cutaneous T-cell lymphoma (CTCL) and adult T-cell leukemia-lymphoma (ATLL). Started May 2022; status: recruiting.
02
Conditions
cutaneous T-cell lymphoma (CTCL)adult T-cell leukemia-lymphoma (ATLL)
Beyond the preview
Go deeper on NCT04848064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04848064.